COVID-19 has turned the world upside down, but the market’s most recent surge has Wall Street observers wondering if the situation is on the mend. Rallying on April 17 thanks to encouraging data from Gilead’s remdesivir COVID-19 drug …
With the coronavirus outbreak spreading rapidly in countries beyond China, so is the fear among investors. Yesterday marked the S&P 500’s worst one-day …
In the stock market, sometimes all it takes is a single catalyst to propel shares to sky-high levels. This is especially common with …
Epizyme Inc (NASDAQ:EPZM) stock underwent a rollercoaster ride on Wednesday, eventually finishing positive at $12.35, nearly 11% increase.
Just in front of its option deadline, Celgene Corporation (NASDAQ:CELG) has re-upped on an existing research and discovery collaboration with Epizyme Inc (NASDAQ:EPZM), a developer …
Advanced Micro Devices, Inc. (NASDAQ:AMD) increased 3.
In a research note published today, H.C.
In a research report released today, Wedbush analyst David Nierengarten reiterated an Outperform rating on Epizyme (NASDAQ:EPZM) with a $52 price target, following the company’s second-quarter financial results and update on …
H.C.
In a research note released this morning, H.C.
